EDN1 mRNA levels in both naive and LPA-treated SAE BC were significantly reduced in the presence of 666-15; this inhibitor returned EDN1 mRNA in LPA-treated samples to baseline levels. This evidence concerns the gene EDN1 and breast cancer.